Quick Dispatch:
Your semaglutide shortage 2025 Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your semaglutide shortage 2025 Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s ships.
Need Help?
Questions about semaglutide shortage 2025 Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for semaglutide shortage 2025 Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s in your area.
Ozempic and Wegovy are no longer in shortage, FDA says
23.53
As of February 21, 2025, the FDA updated its drug shortage list, marking the semaglutide injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A
22.32
FDA Ends Semaglutide Shortage Listing, Contributing to Ongoing Legal Challenges
21.36
The Ozempic Shortage Is Over
21.93
Semaglutide Injections and the FDA
27.12
FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic
26.14
FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many
28.58
